NCT00185263View on ClinicalTrials.gov

Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

November 30, 2008

Conditions
Stable Angina
Interventions
GENETIC

AdF5FGF-4 vs. Placebo

Intracoronary infusion

Sponsors
All Listed Sponsors
lead

Cardium Therapeutics

INDUSTRY

NCT00185263 - Safety and Efficacy of Intracoronary Ad5FGF-4 in Patients With Stable Angina | Biotech Hunter | Biotech Hunter